| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1904036 | BP | negative regulation of epithelial cell apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell apoptotic process. |
HMOX1 |
GO:1904037 | BP | positive regulation of epithelial cell apoptotic process | Any process that activates or increases the frequency, rate or extent of epithelial cell apoptotic process. |
JAK2, TIA1 |
GO:1904044 | BP | response to aldosterone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus. |
CYBB, PARP1 |
GO:1904045 | BP | cellular response to aldosterone | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus. |
AIFM1 |
GO:1904046 | BP | negative regulation of vascular endothelial growth factor production | Any process that stops, prevents or reduces the frequency, rate or extent of vascular endothelial growth factor production. |
NUTF2 |
GO:1904047 | MF | S-adenosyl-L-methionine binding | Interacting selectively and non-covalently with S-adenosyl-L-methionine. |
CBS |
GO:1904049 | BP | negative regulation of spontaneous neurotransmitter secretion | Any process that stops, prevents or reduces the frequency, rate or extent of spontaneous neurotransmitter secretion. |
PARK2 |
GO:1904057 | BP | negative regulation of sensory perception of pain | Any process that stops, prevents or reduces the frequency, rate or extent of sensory perception of pain. |
IL10 |
GO:1904058 | BP | positive regulation of sensory perception of pain | Any process that activates or increases the frequency, rate or extent of sensory perception of pain. |
PTAFR, OPRL1 |
GO:1904059 | BP | regulation of locomotor rhythm | Any process that modulates the frequency, rate or extent of locomotor rhythm. |
OPRL1, ZFHX3 |
GO:1904071 | BP | presynaptic active zone assembly | The aggregation, arrangement and bonding together of a set of components to form a presynaptic active zone. |
PCDH17 |
GO:1904075 | BP | positive regulation of trophectodermal cell proliferation | Any process that activates or increases the frequency, rate or extent of trophectodermal cell proliferation. |
IGF1 |
GO:1904115 | CC | axon cytoplasm | Any cytoplasm that is part of a axon. |
AP3D1, OPA1, KIF1B, KIF4A, SNAPIN, UCHL1, RANGAP1, AP3M2, AP3S2, BLOC1S1, HIF1A, BLOC1S3, MGARP, NDEL1, SPAST, RAB21, BLOC1S6, AP3M1 |
GO:1904117 | BP | cellular response to vasopressin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vasopressin stimulus. |
RANGAP1, CDC6 |
GO:1904153 | BP | negative regulation of retrograde protein transport, ER to cytosol | Any process that stops, prevents or reduces the frequency, rate or extent of retrograde protein transport, ER to cytosol. |
OS9, SVIP, DERL2 |
GO:1904154 | BP | positive regulation of retrograde protein transport, ER to cytosol | Any process that activates or increases the frequency, rate or extent of retrograde protein transport, ER to cytosol. |
BCAP31, EDEM1 |
GO:1904179 | BP | positive regulation of adipose tissue development | Any process that activates or increases the frequency, rate or extent of adipose tissue development. |
TRPM4, NR1H4 |
GO:1904199 | BP | positive regulation of regulation of vascular smooth muscle cell membrane depolarization | Any process that activates or increases the frequency, rate or extent of regulation of vascular smooth muscle cell membrane depolarization. |
TRPM4 |
GO:1904205 | BP | negative regulation of skeletal muscle hypertrophy | Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle hypertrophy. |
IGFBP5 |
GO:1904209 | BP | positive regulation of chemokine (C-C motif) ligand 2 secretion | Any process that activates or increases the frequency, rate or extent of chemokine (C-C motif) ligand 2 secretion. |
POSTN |
GO:1904211 | BP | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol | Any membrane protein proteolysis that is involved in retrograde protein transport, ER to cytosol. |
HM13, RHBDD1 |
GO:1904219 | BP | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity | Any process that activates or increases the frequency, rate or extent of CDP-diacylglycerol-serine O-phosphatidyltransferase activity. |
SERINC5, SERINC2, SERINC1 |
GO:1904222 | BP | positive regulation of serine C-palmitoyltransferase activity | Any process that activates or increases the frequency, rate or extent of serine C-palmitoyltransferase activity. |
SERINC5, SERINC2, SERINC1 |
GO:1904231 | BP | positive regulation of succinate dehydrogenase activity | Any process that activates or increases the frequency, rate or extent of succinate dehydrogenase activity. |
FXN |
GO:1904234 | BP | positive regulation of aconitate hydratase activity | Any process that activates or increases the frequency, rate or extent of aconitate hydratase activity. |
FXN |
GO:1904237 | BP | positive regulation of substrate-dependent cell migration, cell attachment to substrate | Any process that activates or increases the frequency, rate or extent of substrate-dependent cell migration, cell attachment to substrate. |
FN1 |
GO:1904240 | BP | negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly | Any process that stops, prevents or reduces the frequency, rate or extent of VCP-NPL4-UFD1 AAA ATPase complex assembly. |
SVIP |
GO:1904246 | BP | negative regulation of polynucleotide adenylyltransferase activity | Any process that stops, prevents or reduces the frequency, rate or extent of polynucleotide adenylyltransferase activity. |
ZFP36 |
GO:1904247 | BP | positive regulation of polynucleotide adenylyltransferase activity | Any process that activates or increases the frequency, rate or extent of polynucleotide adenylyltransferase activity. |
PABPN1 |
GO:1904251 | BP | regulation of bile acid metabolic process | Any process that modulates the frequency, rate or extent of bile acid metabolic process. |
PANK2 |
GO:1904261 | BP | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | Any process that activates or increases the frequency, rate or extent of basement membrane assembly involved in embryonic body morphogenesis. |
DAG1, PHLDB2, PHLDB1 |
GO:1904262 | BP | negative regulation of TORC1 signaling | Any process that stops, prevents or reduces the frequency, rate or extent of TORC1 signaling. |
SESN2, SESN3, STK11, RNF152, SESN1 |
GO:1904263 | BP | positive regulation of TORC1 signaling | Any process that activates or increases the frequency, rate or extent of TORC1 signaling. |
SEH1L |
GO:1904264 | MF | ubiquitin protein ligase activity involved in ERAD pathway | Any ubiquitin protein ligase activity that is involved in the ERAD pathway (the targeting of endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome). |
TMEM129, PARK2, TRIM25, SYVN1, AMFR, STUB1 |
GO:1904268 | BP | positive regulation of Schwann cell chemotaxis | Any process that activates or increases the frequency, rate or extent of Schwann cell chemotaxis. |
TIAM1 |
GO:1904274 | BP | tricellular tight junction assembly | The aggregation, arrangement and bonding together of a set of components to form a tricellular tight junction. |
LSR |
GO:1904283 | BP | negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I | Any process that stops, prevents or reduces the frequency, rate or extent of antigen processing and presentation of endogenous peptide antigen via MHC class I. |
HFE |
GO:1904288 | MF | BAT3 complex binding | Interacting selectively and non-covalently with a BAT3 complex. |
SGTA, VCP, USP13, AMFR |
GO:1904293 | BP | negative regulation of ERAD pathway | Any process that stops, prevents or reduces the frequency, rate or extent of ERAD pathway. |
USP25 |
GO:1904294 | BP | positive regulation of ERAD pathway | Any process that activates or increases the frequency, rate or extent of ERAD pathway. |
ATXN3, TMEM259, USP13 |
GO:1904300 | BP | positive regulation of transcytosis | Any process that activates or increases the frequency, rate or extent of transcytosis. |
PTAFR |
GO:1904303 | BP | positive regulation of maternal process involved in parturition | Any process that activates or increases the frequency, rate or extent of maternal process involved in parturition. |
PTAFR |
GO:1904306 | BP | positive regulation of gastro-intestinal system smooth muscle contraction | Any process that activates or increases the frequency, rate or extent of gastro-intestinal system smooth muscle contraction. |
PTAFR |
GO:1904317 | BP | cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine stimulus. |
PTAFR |
GO:1904322 | BP | cellular response to forskolin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a forskolin stimulus. |
ADCY3, EFNA5, GNAI1 |
GO:1904338 | BP | regulation of dopaminergic neuron differentiation | Any process that modulates the frequency, rate or extent of dopaminergic neuron differentiation. |
DKK1, TIAM1 |
GO:1904339 | BP | negative regulation of dopaminergic neuron differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation. |
GSK3B |
GO:1904352 | BP | positive regulation of protein catabolic process in the vacuole | Any process that activates or increases the frequency, rate or extent of protein catabolic process in the vacuole. |
CD81, RNF128 |
GO:1904354 | BP | negative regulation of telomere capping | Any process that stops, prevents or reduces the frequency, rate or extent of telomere capping. |
NBN, RAD50 |
GO:1904355 | BP | positive regulation of telomere capping | Any process that activates or increases the frequency, rate or extent of telomere capping. |
MAP2K7, TNKS, MAPK3, MAPK1, NEK2, PRKCQ, NEK7, AURKB, NABP2, TNKS2, MAP3K4 |
GO:1904356 | BP | regulation of telomere maintenance via telomere lengthening | Any process that modulates the frequency, rate or extent of telomere maintenance via telomere lengthening. |
OBFC1 |
GO:1904357 | BP | negative regulation of telomere maintenance via telomere lengthening | Any process that stops, prevents or reduces the frequency, rate or extent of telomere maintenance via telomere lengthening. |
TNKS, PARP1, TNKS2 |
GO:1904378 | BP | maintenance of unfolded protein involved in ERAD pathway | Maintaining an endoplasmic reticulum (ER) protein in an unfolded, soluble state that contributes to its degradation by the cytoplasmic proteasome. Maintaining ER-resident proteins in an unfolded yet soluble state condition after their retro-translocation favors their turnover by the cytosolic proteasome. |
USP13 |
GO:1904379 | BP | protein localization to cytosolic proteasome complex involved in ERAD pathway | Any protein localization to cytosolic proteasome complex that is involved in ERAD pathway. Following their retrotranslocation out of the endoplasmic reticulum, protein substrates must be shuttled to the cytosolic proteasome for degradation. |
ATXN3 |
GO:1904380 | BP | endoplasmic reticulum mannose trimming | Any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC). |
OS9, SYVN1, EDEM1, EDEM3, DERL2, UGGT1, SEL1L, MAN1B1 |
GO:1904381 | BP | Golgi apparatus mannose trimming | Any protein alpha-1,2-demannosylation that takes place in the Golgi apparatus. |
MAN1A1, MAN1C1 |
GO:1904382 | BP | mannose trimming involved in glycoprotein ERAD pathway | The removal of one or more alpha 1,2-linked mannose residues from a mannosylated protein that occurs as part of glycoprotein ER-associated glycoprotein degradation (gpERAD). |
EDEM1, EDEM3, MAN1B1 |
GO:1904383 | BP | response to sodium phosphate | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sodium phosphate stimulus. |
HNRNPD |
GO:1904385 | BP | cellular response to angiotensin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen. |
HSF1, PRKCD, CDC6 |
GO:1904401 | BP | cellular response to Thyroid stimulating hormone | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroid stimulating hormone stimulus. |
RPLP0 |
GO:1904414 | BP | positive regulation of cardiac ventricle development | Any process that activates or increases the frequency, rate or extent of cardiac ventricle development. |
BMPR1A |
GO:1904417 | BP | positive regulation of xenophagy | Any process that activates or increases the frequency, rate or extent of xenophagy. |
RIPK2, MAPK3, TBK1 |
GO:1904424 | BP | regulation of GTP binding | Any process that modulates the frequency, rate or extent of GTP binding. |
CSNK1A1, ARHGEF7 |
GO:1904426 | BP | positive regulation of GTP binding | Any process that activates or increases the frequency, rate or extent of GTP binding. |
CLN5, TGFB2 |
GO:1904428 | BP | negative regulation of tubulin deacetylation | Any process that stops, prevents or reduces the frequency, rate or extent of tubulin deacetylation. |
FRY |
GO:1904430 | BP | negative regulation of t-circle formation | Any process that stops, prevents or reduces the frequency, rate or extent of t-circle formation. |
XRCC5 |
GO:1904431 | BP | positive regulation of t-circle formation | Any process that activates or increases the frequency, rate or extent of t-circle formation. |
ERCC1 |
GO:1904434 | BP | positive regulation of ferrous iron binding | Any process that activates or increases the frequency, rate or extent of ferrous iron binding. |
B2M, HFE |
GO:1904437 | BP | positive regulation of transferrin receptor binding | Any process that activates or increases the frequency, rate or extent of transferrin receptor binding. |
B2M, HFE |
GO:1904447 | BP | folic acid import into cell | The directed movement of folic acid from outside of a cell, across the plasma membrane and into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis. |
SLC46A1 |
GO:1904450 | BP | positive regulation of aspartate secretion | Any process that activates or increases the frequency, rate or extent of aspartate secretion. |
ABAT |
GO:1904454 | MF | ubiquitin-specific protease activity involved in positive regulation of ERAD pathway | Any ubiquitin-specific protease activity that is involved in positive regulation of ERAD pathway. |
USP13 |
GO:1904455 | MF | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway | Any ubiquitin-specific protease activity that is involved in negative regulation of ERAD pathway. |
USP25 |
GO:1904468 | BP | negative regulation of tumor necrosis factor secretion | Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor secretion. |
NR1H4, SYT11 |
GO:1904469 | BP | positive regulation of tumor necrosis factor secretion | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion. |
HSPD1 |
GO:1904479 | BP | negative regulation of intestinal absorption | Any process that stops, prevents or reduces the frequency, rate or extent of intestinal absorption. |
HAMP |
GO:1904482 | BP | cellular response to tetrahydrofolate | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tetrahydrofolate stimulus. |
SHMT1 |
GO:1904491 | BP | protein localization to ciliary transition zone | A process in which a protein is transported to, or maintained in, a location within a ciliary transition zone. |
TMEM107, CC2D2A |
GO:1904501 | BP | positive regulation of chromatin-mediated maintenance of transcription | Any process that activates or increases the frequency, rate or extent of chromatin-mediated maintenance of transcription. |
CTNNB1 |
GO:1904504 | BP | positive regulation of lipophagy | Any process that activates or increases the frequency, rate or extent of lipophagy. |
SPTLC2, ADRB2, HTT |
GO:1904527 | BP | negative regulation of microtubule binding | Any process that stops, prevents or reduces the frequency, rate or extent of microtubule binding. |
MAPRE1, GTSE1 |
GO:1904528 | BP | positive regulation of microtubule binding | Any process that activates or increases the frequency, rate or extent of microtubule binding. |
HSF1 |
GO:1904544 | BP | positive regulation of free ubiquitin chain polymerization | Any process that activates or increases the frequency, rate or extent of free ubiquitin chain polymerization. |
PINK1 |
GO:1904562 | BP | phosphatidylinositol 5-phosphate metabolic process | The chemical reactions and pathways involving phosphatidylinositol 5-phosphate. |
PIKFYVE |
GO:1904568 | BP | cellular response to wortmannin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a wortmannin stimulus. |
CDC5L |
GO:1904582 | BP | positive regulation of intracellular mRNA localization | Any process that activates or increases the frequency, rate or extent of intracellular mRNA localization. |
ZFP36, ZFP36L1 |
GO:1904586 | BP | cellular response to putrescine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a putrescine stimulus. |
HNRNPD |
GO:1904591 | BP | positive regulation of protein import | Any process that activates or increases the frequency, rate or extent of protein import. |
ARHGEF5 |
GO:1904628 | BP | cellular response to phorbol 13-acetate 12-myristate | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus. |
RPLP0, ZFP36L2, CDK6, ZFP36L1 |
GO:1904635 | BP | positive regulation of glomerular visceral epithelial cell apoptotic process | Any process that activates or increases the frequency, rate or extent of glomerular visceral epithelial cell apoptotic process. |
PPARGC1A |
GO:1904637 | BP | cellular response to ionomycin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ionomycin stimulus. |
PPARGC1A |
GO:1904639 | BP | cellular response to resveratrol | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a resveratrol stimulus. |
PPARGC1A |
GO:1904640 | BP | response to methionine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methionine stimulus. |
PCK1, PPARGC1A |
GO:1904646 | BP | cellular response to beta-amyloid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a beta-amyloid stimulus. |
FOXO3, PARP1, CASP4 |
GO:1904651 | BP | positive regulation of fat cell apoptotic process | Any process that activates or increases the frequency, rate or extent of fat cell apoptotic process. |
LEP |
GO:1904659 | BP | glucose transmembrane transport | The directed movement of glucose across a membrane. |
SLC2A10, PPBP, SLC2A1, SLC2A3, SLC2A4, SLC2A5, MFSD4B, SLC2A14, SLC2A6 |
GO:1904667 | BP | negative regulation of ubiquitin protein ligase activity | Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin protein ligase activity. |
MAD2L1, USP44 |
GO:1904668 | BP | positive regulation of ubiquitin protein ligase activity | Any process that activates or increases the frequency, rate or extent of ubiquitin protein ligase activity. |
UBE2C, CDC14B, PLK1, PTEN, CDC20, UBE2S, FZR1 |
GO:1904681 | BP | response to 3-methylcholanthrene | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 3-methylcholanthrene stimulus. |
CHKA |
GO:1904684 | BP | negative regulation of metalloendopeptidase activity | Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity. |
RECK, TIMP3 |